Announcements Trials

Browse Landscape

Phase

Status

Completed 6 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 9 Breast Neoplasms 7 Neoplasms 5 Colorectal Neoplasms 5 Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Triple Negative Breast Neoplasms 2 Sarcoma 2 Pancreatic Neoplasms 2 Melanoma 2 Hematopoietic and Lymphatic System Neoplasm 2 Hematologic Neoplasms 2 Depression 2 Anxiety Disorders 2 Alzheimer Disease 2 Advanced Malignant Solid Neoplasm 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Tobacco Smoking 1 Testicular Neoplasms 1 Spondylitis, Ankylosing 1 Specific Learning Disorder 1 Smoking Cessation 1 Smoking 1 Signs and Symptoms 1 Sedentary Behavior 1 Rectal Neoplasms 1 Psoriasis 1 Pancreatic Diseases 1 Pancreatic Cyst 1

Interventions

Capecitabine 29 Oxaliplatin 28 Fluorouracil 16 Radiotherapy 15 Drug Therapy 11 Leucovorin 10 Bevacizumab 10 Surgical Procedures, Operative 9 Chemoradiotherapy 8 Radiation 7 sintilimab 6 Consolidation Chemotherapy 6 tislelizumab 5 spartalizumab 5 XELOX 5 Specimen Handling 5 Irinotecan 5 Folfox protocol 5 trifluridine tipiracil drug combination 4 Neoadjuvant Therapy 4 Endoscopy 4 Cetuximab 4 Biopsy 4 toripalimab 3 pembrolizumab 3 irinotecan sucrosofate 3 X-Rays 3 Radiotherapy, Intensity-Modulated 3 Proctectomy 3 Mastectomy, Segmental 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Rectal Neoplasms × Methods × Clear all

NCT04288999 2020-06-04

JCOG1801

National Cancer Center Hospital East

Phase 3 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡